Hypertensive Disorders in Pregnancy Are Associated With Congenital Heart Defects in Offspring: A Systematic Review and Meta-Analysis
Open Access
- 28 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 842878
Abstract
Background: Although research indicates an association between hypertensive disorders of pregnancy (HDP) and congenital heart defects (CHDs) in offspring, consistency is still lacking. Therefore, we aimed to synthesize the updated published epidemiologic evidence to estimate the association of maternal HDP with the risk of total CHDs and its phenotypes in offspring.Methods: A systematic search of Web of Science Database, PubMed, and Embase were searched from inception through April 30, 2021 based on a preprepared protocol, and the reference lists were also manually searched. The combined risk estimates were calculated using either the fixed-effect models or random-effect models. Possible heterogeneity moderators were detected by subgroup, sensitivity analyses, and Galbraith plot.Results: Twenty-four studies involving 477,839 CHDs cases among 40,394,699 participants were included in our meta-analysis. Mothers who had HDP exposure were significantly associated with an increased risk of total CHDs compared with non-exposure. When maternal HDP exposure was further subdivided into pre-eclampsia (OR = 1.79, 95% CI: 1.50–2.13), gestational hypertension (OR = 1.16, 95% CI: 1.02–1.31), and chronic hypertension (OR = 1.68, 95% CI: 1.49–1.89), a significantly increased risk of total CHDs were still presented. Furthermore, a statistically significant increased association was found between maternal HDP exposure and most CHD phenotypes. Besides, relevant heterogeneity moderators have been identified by subgroup and sensitivity analyses.Conclusion: Our study suggested that maternal HDP exposure may be associated with an increase in the risk of CHDs in offspring. These findings highlight the need for greater surveillance of pregnant women with HDP exposure to allow early prevention that may be good for reducing the risk of CHDs in offspring.Clinical Trial Registration: [www.ClinicalTrials.gov], identifier [CRD42021268093].Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 53 references indexed in Scilit:
- If we know so much about preeclampsia, why haven’t we cured the disease?Journal of Reproductive Immunology, 2013
- Risk and protective factors in the origin of conotruncal defects of heart—a population‐based case–control studyAmerican Journal of Medical Genetics Part A, 2013
- Gestational and family risk factors for carriers of congenital heart defects in southern BrazilPediatrics International, 2011
- Guidelines for the management of hypertensive disorders of pregnancy 2008Australian and New Zealand Journal of Obstetrics and Gynaecology, 2009
- Obstetric outcome of 6346 pregnancies with infants affected by congenital heart defectsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafishDevelopmental Dynamics, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Pathogenetic mechanisms of congenital cardiovascular malformations revisitedSeminars in Perinatology, 1996
- Risk factors for cardiovascular malformations in FinlandEuropean Journal of Epidemiology, 1990
- Risk factors in congenital heart diseaseEuropean Journal of Epidemiology, 1989